Hasil Pencarian - Satoshi Serada
- Menampilkan 1 - 14 hasil dari 14
-
1
-
2
Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A r... oleh Takaaki Ishida, Takuya Kotani, Satoshi Serada, Minoru Fujimoto, Tohru Takeuchi, Shigeki Makino, Tetsuji Naka
Diterbitkan 2020-01-01
Artikel -
3
-
4
-
5
Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells oleh Hayato Urushima, Minoru Fujimoto, Takashi Mishima, Tomoharu Ohkawara, Hiromi Honda, Hyun Lee, Hirohisa Kawahata, Satoshi Serada, Tetsuji Naka
Diterbitkan 2017-06-01
Artikel -
6
Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma. oleh Hiromi Honda, Minoru Fujimoto, Shintaro Miyamoto, Nobuhisa Ishikawa, Satoshi Serada, Noboru Hattori, Shintaro Nomura, Nobuoki Kohno, Akihito Yokoyama, Tetsuji Naka
Diterbitkan 2016-01-01
Artikel -
7
Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. oleh Lingli Yang, Satoshi Serada, Minoru Fujimoto, Mika Terao, Yorihisa Kotobuki, Shun Kitaba, Saki Matsui, Akira Kudo, Tetsuji Naka, Hiroyuki Murota, Ichiro Katayama
Diterbitkan 2012-01-01
Artikel -
8
Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma oleh Shun Uchida, Satoshi Serada, Yuji Suzuki, Eiji Funajima, Kei Kitakami, Kazumasa Dobashi, Satomi Tamatani, Yuichi Sato, Takaaki Beppu, Kuniaki Ogasawara, Testuji Naka
Diterbitkan 2024-04-01
Artikel -
9
A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma oleh Eri Munekage, Satoshi Serada, Shigehiro Tsujii, Keiichiro Yokota, Keita Kiuchi, Kenji Tominaga, Minoru Fujimoto, Mizuki Kanda, Sunao Uemura, Tsutomu Namikawa, Taisei Nomura, Ichiro Murakami, Kazuhiro Hanazaki, Tetsuji Naka
Diterbitkan 2021-09-01
Artikel -
10
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer oleh Mizuki Kanda, Satoshi Serada, Kosuke Hiramatsu, Masashi Funauchi, Kengo Obata, Satoshi Nakagawa, Tomoharu Ohkawara, Okinori Murata, Minoru Fujimoto, Fumiko Chiwaki, Hiroki Sasaki, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
Diterbitkan 2023-01-01
Artikel -
11
Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer oleh Yoshikazu Nagase, Kosuke Hiramatsu, Masashi Funauchi, Mayu Shiomi, Tatsuo Masuda, Mamoru Kakuda, Satoshi Nakagawa, Ai Miyoshi, Shinya Matsuzaki, Eiji Kobayashi, Toshihiro Kimura, Satoshi Serada, Yutaka Ueda, Tetsuji Naka, Tadashi Kimura
Diterbitkan 2022-06-01
Artikel -
12
Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection. oleh Etsuko Kajimoto, Masayuki Endo, Minoru Fujimoto, Shinya Matsuzaki, Makoto Fujii, Kazunobu Yagi, Aiko Kakigano, Kazuya Mimura, Takuji Tomimatsu, Satoshi Serada, Makoto Takeuchi, Kiyoshi Yoshino, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
Diterbitkan 2020-01-01
Artikel -
13
GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab oleh Daiki Kato, Tomonori Yaguchi, Takashi Iwata, Yuki Katoh, Kenji Morii, Kinya Tsubota, Yoshiaki Takise, Masaki Tamiya, Haruhiko Kamada, Hiroki Akiba, Kouhei Tsumoto, Satoshi Serada, Tetsuji Naka, Ryohei Nishimura, Takayuki Nakagawa, Yutaka Kawakami
Diterbitkan 2020-03-01
Artikel -
14
Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure oleh Koji Saito, MD, Minoru Fujimoto, MD, PhD, Eiji Funajima, MSc, Satoshi Serada, PhD, Tomoharu Ohkawara, MD, Masayuki Ishihara, MD, PhD, Mamiko Yamada, MD, PhD, Hisato Suzuki, MD, PhD, Fuyuki Miya, PhD, Kenjiro Kosaki, MD, PhD, Mikiya Fujieda, MD, PhD, Tetsuji Naka, MD, PhD
Diterbitkan 2024-11-01
Artikel